Core Insights - The medical ETF (159865) has seen a net inflow of 620 million units, indicating strong investor interest in medical assets [1] - The World Conference on Lung Cancer (WCLC) will take place from September 6-9, 2025, in Barcelona, Spain, where Chinese pharmaceutical companies will showcase innovative research results [1] - Key clinical data will be presented at the conference, including results from Kangfang Biotech's AK112 and AK104 studies, as well as data from Heng Rui Pharma's SHR-4849 and other companies [1] Investment Opportunities - Investors interested in the pharmaceutical sector can consider the medical ETF (159828) to capitalize on related opportunities [1] - The upcoming WCLC conference is expected to highlight significant advancements in lung cancer treatments from various Chinese pharmaceutical firms [1]